Cell Separation Industry Overview
The global cell separation market size is expected to reach USD 25.8 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 18.8% from 2021 to 2028. Growing focus on biomolecule and cancer research, and rising incidence of chronic and infectious diseases, including the outbreak of COVID-19, are major factors contributing towards the growth of the market. Cell separation products are widely used by researchers and healthcare professionals for the development and production of novel therapies such as gene therapies and regenerative medicines. Continuous technological advancements and the introduction of more efficient products by key players have significantly supported the market growth.
Cell Separation Market Segmentation
Grand View Research has segmented the global cell separation market on the basis of product, cell type, technique, application, end use, and region:
Based on the Product Insights, the market is segmented into consumables, instruments.
In 2020, the consumables segment dominated the market for cell separation and accounted for the largest revenue share of 62.3%. This segment held the largest market share due to repeated purchases of consumables.
This segment held the largest market share due to repeated purchases of consumables. In addition, rising investments in R&D by biotechnology and biopharmaceutical companies for the development of advanced biologics including monoclonal antibodies and vaccines are also driving the segment.
The instruments segment is estimated to exhibit a lucrative growth rate during the forecast period, due to product advancements.
Technological advancement in instruments provides efficient cell separation in research, diagnostics, and therapeutics application.
The industry for instruments is anticipated to witness significant growth during the forecast period. However, the high cost of instruments is expected to restrain the market growth.
Based on the Cell Type Insights, the market is segmented into human, animal.
The human cell segment dominated the market for cell separation and held the largest revenue share of 44.8% in 2020.
Rising focus on human and cancer research and varied applications of isolated human cells in biopharmaceuticals development, clinical trials, and research are among the major factors contributing to its largest share.
Moreover, favorable reimbursement policies pertaining to personalized medicine in developed countries further boost the demand for human cell isolation.
The animal cells segment is anticipated to exhibit a lucrative growth rate during the forecast period.
The growing focus of government, private, and healthcare companies on new drug discoveries and development is a key factor driving the segment growth.
Drug discovery and development involve animal cells' use to examine efficacy, the pharmacokinetics of new drug molecules, and preliminary toxicity.
Based on the Technique Insights, the market is segmented into centrifugation, surface marker, filtration.
The centrifugation segment dominated the market for cell separation and held the largest revenue share of 42.7% in 2020. This is due to the extensive usage of this technique by academic institutes, research laboratories, and biotechnology and biopharmaceutical companies.
Centrifugation is one of the most important steps in cell isolation. Density gradient centrifugation and differential centrifugation are most commonly used for cell isolation.
Density gradient centrifugation makes use of molecular weights of the particles to be separated, whereas differential centrifugation makes use of a lysate to break cell membranes to separate them.
The surface marker and filtration segments are expected to witness significant growth in the near future. Rising investments in manufacturing infrastructure by companies and product advancements are prime factors supporting the growth of this segment.
Manufacturers are engaged in the usage of advanced filtration system surface markers for production and research processes to ensure a better quality of the end product.
Based on the Application Insights, the market is segmented into biomolecule isolation, cancer research, stem cell research, tissue regeneration, in vitro diagnostics, therapeutics.
The biomolecule isolation segment dominated the market for cell separation and accounted for the highest revenue share of 30.8% in 2020.
The growing focus on the production of biopharmaceuticals, including biosimilar, monoclonal antibodies, and recombinant proteins, is the most predominant factor contributing to its highest share. Also, increasing government funding for new drug development propels the market growth.
The cancer research and stem cell research segments are projected to exhibit lucrative growth over the study period. Rising investment in cell-based research by companies and research laboratories is a key factor that can be attributed to the segment growth.
Several public-private organizations are investing heavily in cancer research owing to the increasing global incidence of cancer, thus, driving the demand for innovative separation solutions.
Based on the End-use Insights, the market is segmented into research laboratories and institutes, hospitals and diagnostic laboratories, cell banks, biotechnology and biopharmaceutical companies.
The research laboratories and institutes segment accounted for the largest revenue share of 43.9% in 2020 and is expected to hold its position throughout the study period.
This can be attributed to increasing R&D initiatives by research institutions to develop novel therapies in oncology and neuroscience. The growing number of research institutes and laboratories across the globe is also anticipated to be a major driver of the segment.
For instance, in April 2017, the New York Stem Cell Foundation (NYSCF) opened a new Research Institute in Manhattan, which is focused on conducting the most advanced stem cell.
The biotechnology and pharmaceutical companies segment exhibited significant growth over the forecast period due to increasing R&D investment by these companies for the development of new products.
Cell Separation Regional Outlook
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Key Companies Profile & Market Share Insights
Key players are engaged in organic and inorganic growth strategies such as product development, collaborations, partnerships, mergers, and acquisitions to garner high market share.
Some prominent players in the global Cell Separation market include:
Thermo Fisher Scientific, Inc.
Becton, Dickinson and Company
Danaher
Beckman Coulter, Inc.
Cytiva
Terumo Corporation
STEMCELL Technologies Inc.
Bio-Rad Laboratories, Inc.
Merck KGaA
Order a free sample PDF of the Cell Separation Market Intelligence Study, published by Grand View Research.